Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1978 Jun;32(3):411–418.

Effect of niridazole in cellular immunity in vivo and in vitro.

W Solbach, H Wagner, M Röllinghoff
PMCID: PMC1541333  PMID: 357051

Abstract

The influence of niridazole, an anti-helminthic drug, on cell-mediated immune responses was investigated. Allograft rejection in mice as well as the in vitro induction of cytotoxic T lymphocytes (CTL) against murine alloantigen were used as the test system. Repeated daily oral treatment of host mice with niridazole (100 mg/kg) prior to and during allotransplantation resulte in the postponement of graft rejection, inducing a transitory functional state of allograft tolerance. The time interval between the termination of niridazole administration and onset of graft rejection was estimated to be 5-7 days. In order to test the effect of niridazole or its derivatives on the in vitro induction of alloreactive CTL, the serum or urine of mice which were treated with niridazole were added to the cultures, instead of adding niridazole directly to the cultures. Such serum and urine were found to be inhibitory for in vitro induction of CTL. The serum and urine had no effect on the effector phase of CTL.

Full text

PDF
411

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Daniels J. C., Fajardo I., David J. R. Two stages in lymphocyte mediator production by differential susceptibility to blockade using niridazole. Proc Natl Acad Sci U S A. 1975 Nov;72(11):4569–4572. doi: 10.1073/pnas.72.11.4569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Daniels J. C., Warren K. S., David J. R. Studies on the mechanism of suppression of delayed hypersensitivity by the antischistosomal compund niridazole. J Immunol. 1975 Nov;115(5):1414–1421. [PubMed] [Google Scholar]
  3. Faigle J. W., Keberle H. Metabolism of niridazole in various species, including man. Ann N Y Acad Sci. 1969 Oct 6;160(2):544–557. doi: 10.1111/j.1749-6632.1969.tb15874.x. [DOI] [PubMed] [Google Scholar]
  4. Jones B. M., Bird M., Howells M., Massey P. R., Millar D., Miller J. J., Reeves S., Salaman J. R. Inhibition of human mixed lymphocyte reactions by sera and urine dialysates from niridazole-treated rats. Transplantation. 1977 Aug;24(2):134–140. doi: 10.1097/00007890-197708000-00007. [DOI] [PubMed] [Google Scholar]
  5. Lucas A. O., Oduntan S. O., Gilles H. M. Niridazole in guinea worm infection. Ann N Y Acad Sci. 1969 Oct 6;160(2):729–739. doi: 10.1111/j.1749-6632.1969.tb15892.x. [DOI] [PubMed] [Google Scholar]
  6. Lucas S. V., Daniels J. C., Schubert R. D., Simpson J. M., Mahmoud A. A., warren K. S., David J. R., Webster L. T. Identification and purification of immunosuppressive activity in the urine of rats and a human patient treated with niridazole. J Immunol. 1977 Feb;118(2):418–422. [PubMed] [Google Scholar]
  7. MEDAWAR P. B. The use of antigenic tissue extracts to weaken the immunological reaction against skin homografts in mice. Transplantation. 1963 Jan;1:21–38. doi: 10.1097/00007890-196301010-00004. [DOI] [PubMed] [Google Scholar]
  8. Mahmoud A. A., Mandel A., Warren K., Webster L. T., Jr Niridazole. II. A potent long-acting suppressant of cellular hypersensitivity. J Immunol. 1975 Jan;114(1 Pt 2):279–283. [PubMed] [Google Scholar]
  9. Mahmoud A. A., Warren K. S. Anti-inflammatory effects of tartar emetic and niridazole: suppression of schistosome egg granuloma. J Immunol. 1974 Jan;112(1):222–228. [PubMed] [Google Scholar]
  10. Mandel M. A., Asofsky R. The effects of heterologous anti-thymocyte sera in mice. I. The use of a graft-vs.-host assay as a measure of homograft reactivity. J Immunol. 1968 Jun;100(6):1319–1325. [PubMed] [Google Scholar]
  11. Pelley R. P., Pelley R. J., Stavitsky A. B., Mahmoud A. A., Warren K. S. Niridazole, a potent long-acting suppressant of cellular hypersensitivity. III. Minimal suppression of antibody responses. J Immunol. 1975 Dec;115(6):1477–1482. [PubMed] [Google Scholar]
  12. Röllinghoff M., Pfizenmeier K., Trostmann H., Wagner H. T cell proliferation in the mixed lymphocyte culture does not necessarily result in the generation of cytotoxic T effector cells. Eur J Immunol. 1975 Aug;5(8):560–564. doi: 10.1002/eji.1830050811. [DOI] [PubMed] [Google Scholar]
  13. Salaman J. R., Bird M., Godfrey A. M., Jones B., Millar D., Miller J. Prolonged allograft survival with niridazole, azathioprine, and prednisolone. Transplantation. 1977 Jan;23(1):29–32. doi: 10.1097/00007890-197701000-00005. [DOI] [PubMed] [Google Scholar]
  14. Stewart P. B. Failure of 6-mercaptopurine to prolong the survival of skin allografts in mice. Transplantation. 1969 Jun;7(6):498–505. doi: 10.1097/00007890-196906000-00006. [DOI] [PubMed] [Google Scholar]
  15. Webster L. T., Jr, Butterworth A. E., Mahmoud A. A., Mngola E. N., Warren K. S. Suppression of delayed hypersensitivity in schistosome-infected patients by niridazole. N Engl J Med. 1975 May 29;292(22):1144–1147. doi: 10.1056/NEJM197505292922202. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES